Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kojiroh Mori"'
Autor:
Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, Hideki Fujii, Yoshio Sumida, Makoto Yamada, Kojiroh Mori, Saiyu Tanaka, Tomohiro Maekawa, Yusuke Ebisutani, Akiko Yamamoto, Shinji Takamatsu, Masashi Yoneda, Norifumi Kawada, Kazuaki Chayama, Toshiji Saibara, Tetsuo Takehara, Eiji Miyoshi, Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD)
Publikováno v:
Hepatology Communications, Vol 1, Iss 8, Pp 780-791 (2017)
In contrast to patients with viral hepatitis, patients with nonalcoholic fatty liver disease (NAFLD) can progress to hepatocellular carcinoma during the initial stages of liver fibrosis. Development and implementation of noninvasive methods for diagn
Externí odkaz:
https://doaj.org/article/77fb315750e24030ad6716b0f0aaaf24
Autor:
Yoshito Itoh, Kota Yano, Shinya Okishio, Takeshi Okanoue, Nozomi Tochiki, Seita Kataoka, Kanji Yamaguchi, Michihisa Moriguchi, Yuya Seko, Keiichiroh Okuda, Atsushi Umemura, Saiyu Tanaka, Kojiroh Mori, Aya Takahashi
Publikováno v:
Liver International. 40:1686-1692
Background & aims PNPLA3 rs738409 has been associated with increased risks of fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Recently, carriage of the rs6834314 G allele, which is in high linkage with rs72613567 of 17-beta-hydro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e1af972b62e462d3aab227cb028d97
https://doi.org/10.1111/liv.14495
https://doi.org/10.1111/liv.14495
Autor:
Norifumi Kawada, Tetsuo Takehara, Hideyuki Hyogo, Yoshihiro Kamada, Shinji Takamatsu, Yoshio Sumida, Tomohiro Maekawa, Kojiroh Mori, Masashi Yoneda, Masafumi Ono, Yusuke Ebisutani, Saiyu Tanaka, Toshiji Saibara, Kazuaki Chayama, Eiji Miyoshi, Akiko Yamamoto, Makoto Yamada, Hideki Fujii
Publikováno v:
Hepatology Communications
In contrast to patients with viral hepatitis, patients with nonalcoholic fatty liver disease (NAFLD) can progress to hepatocellular carcinoma during the initial stages of liver fibrosis. Development and implementation of noninvasive methods for diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63296116f384731b33b66ffd6b8a9424
https://doi.org/10.1002/hep4.1080
https://doi.org/10.1002/hep4.1080
Autor:
Yasuhito Tanaka, Kentaro Matsuura, Saiyu Tanaka, Yoshito Itoh, Kohichiroh Yasui, Kanji Yamaguchi, Masashi Takemura, Yuya Seko, Naomi Mochizuki, Atsushi Umemura, Tasuku Hara, Taichiro Nishikawa, Keiichiro Okuda, Michihisa Moriguchi, Hiroyoshi Taketani, Kenichi Nishioji, Masao Kobayashi, Mai Kamaguchi, Kojiroh Mori, Naoki Mizuno
Publikováno v:
Journal of Gastroenterology. 53:438-448
Hepatic fibrosis is an independent risk factor for mortality and liver-related events in patients with nonalcoholic fatty liver disease (NAFLD). PNPLA3 rs738409 has been associated with fibrosis in viral and non-viral hepatitis. TLL1 rs17047200 also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105aaec0cb338a6df99994ff61e593b4
https://doi.org/10.1007/s00535-017-1372-8
https://doi.org/10.1007/s00535-017-1372-8
Autor:
Hiroshi Ishiba, Kohichiroh Yasui, Kanji Yamaguchi, Yoshito Itoh, Michihisa Moriguchi, Hiroyoshi Taketani, Kojiroh Mori, Yuya Seko, Akira Okajima, Atsushi Umemura, Keiji Shimada, Tasuku Hara, Yoshio Sumida, Shunsuke Imai, Taichiro Nishikawa, Saiyu Tanaka, Kazuyuki Kanemasa
Publikováno v:
Hepatology Research. 47:1083-1092
Aim Some patients with non-alcoholic fatty liver disease (NAFLD) develop hepatocellular carcinoma (HCC). Patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 (encoding the I148M variant) has been associated with advanced fibrosis and HCC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bf123e17d6ae1ac9bd8787a20f64c36
https://doi.org/10.1111/hepr.12840
https://doi.org/10.1111/hepr.12840
Autor:
Kohichiroh Yasui, Saiyu Tanaka, Taichiro Nishikawa, Hiroshi Ishiba, Akira Okajima, Keiji Shimada, Yoshio Sumida, Kojiroh Mori, Atsushi Umemura, Tasuku Hara, Shunsuke Imai, Michihisa Moriguchi, Kanji Yamaguchi, Hiroyoshi Taketani, Yuya Seko, Yoshito Itoh, Kazuyuki Kanemasa
Publikováno v:
Hepatology Research. 47:1072-1078
Aim No pharmacological therapies have been established for non-alcoholic fatty liver disease (NAFLD). Sodium glucose cotransporter 2 inhibitor (SGLT2I) was developed for the treatment of adults with type 2 diabetes mellitus (T2DM). The aim of this re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26912bf000a699011eb650ad70d92f18
https://doi.org/10.1111/hepr.12834
https://doi.org/10.1111/hepr.12834
Autor:
Kohichiroh Yasui, Yuya Seko, Michihisa Moriguchi, Taichiro Nishikawa, Saiyu Tanaka, Yoshio Sumida, Tasuku Hara, Akira Okajima, Shunsuke Imai, Keiji Shimada, Kanji Yamaguchi, Hiroyoshi Taketani, Hiroshi Ishiba, Atsushi Umemura, Kazuyuki Kanemasa, Yoshito Itoh, Kojiroh Mori
Publikováno v:
Hepatology Research. 47:1206-1211
Aims No pharmacological therapies have been established for non-alcoholic fatty liver disease (NAFLD) with type 2 diabetes mellitus (T2DM). The aim of this retrospective study is to evaluate the efficacy and safety of dulaglutide, a novel glucagon-li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4de6c95dbeb3d3235c37788ef4e4e449
https://doi.org/10.1111/hepr.12837
https://doi.org/10.1111/hepr.12837
Autor:
Kohichiroh Yasui, Hiroyoshi Taketani, Yuya Seko, Kanji Yamaguchi, Akira Okajima, Tasuku Hara, Hironori Mitsuyoshi, Saiyu Tanaka, Yoshito Itoh, Kojiroh Mori, Kazuyuki Kanemasa, Hiroshi Ishiba, Yoshio Sumida, Michihisa Moriguchi, Shunsuke Imai, Masahito Minami
Publikováno v:
Hepatology Research. 45:E53-E61
Aim Some cases with non-alcoholic fatty liver disease (NAFLD), particularly non-alcoholic steatohepatitis (NASH), can ultimately progress to liver cirrhosis. However, studies to clarify factors predictive of histological change in patients with NASH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::903d186f0c26eb73c82c79cb7527d446
https://doi.org/10.1111/hepr.12456
https://doi.org/10.1111/hepr.12456
Autor:
Kohichiroh Yasui, Shunsuke Imai, Atsushi Umemura, Hiroyoshi Taketani, Kanji Yamaguchi, Kojiroh Mori, Akira Okajima, Keiji Shimada, Saiyu Tanaka, Michihisa Moriguchi, Yoshio Sumida, Yoshito Itoh, Kazuyuki Kanemasa, Yuya Seko, Taichiro Nishikawa, Tasuku Hara, Hiroshi Ishiba
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 48(3)
Background Type 2 diabetes mellitus (T2DM) is a major complication of patients with nonalcoholic fatty liver disease (NAFLD). The aim of this retrospective study is to determine the risk factor for development of T2DM in patients with biopsy proven N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbebe54c8863d356335206b54d533e4
https://pubmed.ncbi.nlm.nih.gov/28628263
https://pubmed.ncbi.nlm.nih.gov/28628263
Autor:
Yoshio Sumida, Hironori Mitsuyoshi, Hiroshi Ishiba, Kohichiroh Yasui, Tasuku Hara, Saiyu Tanaka, Shunsuke Imai, Akira Okajima, Masahito Minami, Yoshikazu Yonei, Michihisa Moriguchi, Hiroyoshi Taketani, Kojiroh Mori, Yoshito Itoh, Kazuyuki Kanemasa, Yuya Seko, Kanji Yamaguchi
Publikováno v:
Hepatology Research. 45:771-781
Aim Growth hormone (GH) deficiency may be associated with histological progression of non-alcoholic fatty liver disease (NAFLD) which includes non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). Insulin-like growth factor 1 (IG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30b60f00307513cd163e91d6a7f39040
https://doi.org/10.1111/hepr.12408
https://doi.org/10.1111/hepr.12408